Preliminary research is the early-stage investigative work you do before launching a full study or project. Its purpose is to scope out a topic, test whether your approach is workable, and identify gaps in existing knowledge. Rather than proving or disproving a specific claim, preliminary research helps you figure out the right questions to ask and whether a larger investment of time and resources makes sense.
The term shows up in two overlapping contexts: academic coursework (where it means the background reading and brainstorming you do before writing a paper) and scientific research (where it refers to small-scale studies designed to prepare for a bigger investigation). Both share the same core idea: gather enough information to move forward with confidence.
Preliminary Research in Academic Projects
If you’re working on a paper or thesis, preliminary research is essentially your scouting phase. You’re reading broadly, talking to classmates or advisors, and scanning the existing conversation around your topic. The goal isn’t to become an expert yet. It’s to identify what people in the field are actually discussing, find where the interesting debates are, and narrow your focus to something specific enough to be useful.
This phase typically involves searching online databases, skimming journal articles and books, and taking notes on recurring themes. You’re also figuring out logistics: what types of sources your assignment requires, whether you need primary sources like archival documents or interviews, and where you’d find them. These early notes help you develop a research question, which becomes the foundation for everything that follows. Without this step, students often end up with a topic that’s either too broad to cover meaningfully or too narrow to find enough sources.
Preliminary Research in Science and Medicine
In scientific contexts, preliminary research takes a more structured form. It includes pilot studies, feasibility studies, and exploratory investigations, all designed to lay the groundwork before committing to a large, expensive trial.
A feasibility study asks a basic question: can this research actually be done? It tests whether you can recruit enough participants, whether your measurement tools work, and whether the overall design holds up in practice. A pilot study is more specific. It mimics the structure of the intended full-scale trial, often including a control group and randomization, but on a smaller scale. The distinction matters because pilot studies are meant to rehearse the real thing, while feasibility studies might test just one piece of the puzzle. Both fall under the umbrella of preliminary research, and neither is meant to produce definitive answers about whether a treatment works.
Exploratory studies take yet another approach. These are often qualitative, using interviews or open-ended surveys to investigate a topic that hasn’t been well studied. The aim is inductive: rather than starting with a hypothesis and testing it, you collect observations and let patterns emerge. Those patterns then become formal hypotheses that can be tested with larger quantitative studies later.
Why It Matters for Funding
In fields like biomedical science, preliminary data can make or break a grant application. Funding agencies want evidence that your proposed study is worth backing. Showing that you’ve already done small-scale work, confirmed your methods are sound, and identified promising early results dramatically strengthens your case.
That said, preliminary data isn’t always required. The National Institutes of Health, for example, offers specific grants for early-stage investigators pursuing innovative projects in new research directions where no preliminary data exist. These grants acknowledge that sometimes the most important work is in uncharted territory. But for most standard research grants, having preliminary findings signals to reviewers that you’ve done your homework and that a larger study is likely to succeed.
How Sample Sizes Work
One of the most common questions about preliminary studies is how many participants you need. The answer depends on what effect you’re trying to detect. Current guidelines for pilot trials suggest a total sample size ranging from 24 to 70 participants across all groups, depending on which rule of thumb you follow. One widely cited recommendation calls for at least 12 participants per treatment arm, while others push for 35 per arm to reduce imprecision in the estimates.
For a trial designed to detect a large treatment effect, as few as 10 participants per group may be sufficient in the pilot phase. For small effects, that number climbs to 25 or even 75 per group. These are dramatically smaller than what a full-scale trial would require, which is the whole point. You’re investing a fraction of the resources to learn whether the full investment is justified.
What Preliminary Results Can and Can’t Tell You
Preliminary findings are inherently limited, and understanding those limits is important if you’re reading or conducting this type of research. The most critical limitation involves statistical significance. With small sample sizes, a study might detect a real effect but lack the statistical power to confirm it definitively. Conversely, a larger preliminary study might produce a “statistically significant” result that turns out to be clinically meaningless.
Consider a cancer treatment study that finds a statistically significant improvement in survival, but the actual difference is only 10 days. Statistically, the numbers check out. Practically, most oncologists would consider that improvement irrelevant, especially when weighed against added side effects and costs. This gap between statistical and clinical significance is something preliminary research is especially prone to because the sample sizes are too small to reliably estimate how big the real-world effect will be.
For this reason, experts widely agree that preliminary studies should not be used to estimate treatment effects or draw conclusions about whether an intervention works. Their value lies in testing procedures, refining measurement tools, and confirming that a full-scale study is feasible.
Ethics Review Requirements
If your preliminary research involves human participants, it requires ethics approval just like any other study. In the United States, an Institutional Review Board (IRB) must review and approve clinical investigations involving people, regardless of whether the research takes place at a university, a hospital, or a private practice. This applies to studies involving FDA-regulated products whether they’re marketed or experimental.
The “preliminary” label doesn’t exempt a study from these requirements. Even a small pilot study collecting health data from 12 participants needs the same ethical oversight as a 500-person trial. The review process examines whether participants are adequately informed, whether risks are minimized, and whether the study design is sound enough to justify asking people to participate.
Publishing Preliminary Findings
Journals handle preliminary results in several ways. Many researchers share early findings through preprint servers, which make the work publicly available before formal peer review. Major journals like PLOS ONE explicitly welcome manuscripts that have been posted as preprints, and this practice has become increasingly common across scientific disciplines.
Some journals also accept Registered Report Protocols, which describe a study’s design and rationale before data collection begins. This format is particularly useful for preliminary work because it allows the research community to evaluate and refine a study’s methods early on. Once the study is complete, a follow-up article reports the outcomes. This two-stage process helps prevent the common problem of preliminary findings being over-interpreted or selectively reported after the fact.